These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 34012926)

  • 1.
    Murros KE; Huynh VA; Takala TM; Saris PEJ
    Front Cell Infect Microbiol; 2021; 11():652617. PubMed ID: 34012926
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Huynh VA; Takala TM; Murros KE; Diwedi B; Saris PEJ
    Front Cell Infect Microbiol; 2023; 13():1181315. PubMed ID: 37197200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The link between increased Desulfovibrio and disease severity in Parkinson's disease.
    Nie S; Jing Z; Wang J; Deng Y; Zhang Y; Ye Z; Ge Y
    Appl Microbiol Biotechnol; 2023 May; 107(9):3033-3045. PubMed ID: 36995383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen Sulfide Produced by Gut Bacteria May Induce Parkinson's Disease.
    Murros KE
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease and the gut: Models of an emerging relationship.
    Bindas AJ; Kulkarni S; Koppes RA; Koppes AN
    Acta Biomater; 2021 Sep; 132():325-344. PubMed ID: 33857691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alteration of intestinal mucosal α-synuclein expression and mucosal microbiota in Parkinson's disease.
    Shi J; Wang Y; Chen D; Xu X; Li W; Li K; He J; Su W; Luo Q
    Appl Microbiol Biotechnol; 2023 Mar; 107(5-6):1917-1929. PubMed ID: 36795141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease.
    Kelly LP; Carvey PM; Keshavarzian A; Shannon KM; Shaikh M; Bakay RA; Kordower JH
    Mov Disord; 2014 Jul; 29(8):999-1009. PubMed ID: 24898698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut bacterial profiles in Parkinson's disease: A systematic review.
    Li Z; Liang H; Hu Y; Lu L; Zheng C; Fan Y; Wu B; Zou T; Luo X; Zhang X; Zeng Y; Liu Z; Zhou Z; Yue Z; Ren Y; Li Z; Su Q; Xu P
    CNS Neurosci Ther; 2023 Jan; 29(1):140-157. PubMed ID: 36284437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colonic bacterial composition in Parkinson's disease.
    Keshavarzian A; Green SJ; Engen PA; Voigt RM; Naqib A; Forsyth CB; Mutlu E; Shannon KM
    Mov Disord; 2015 Sep; 30(10):1351-60. PubMed ID: 26179554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
    Nielsen SD; Pearson NM; Seidler K
    Brain Res; 2021 Oct; 1769():147609. PubMed ID: 34371014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.
    Barrenschee M; Zorenkov D; Böttner M; Lange C; Cossais F; Scharf AB; Deuschl G; Schneider SA; Ellrichmann M; Fritscher-Ravens A; Wedel T
    Acta Neuropathol Commun; 2017 Jan; 5(1):1. PubMed ID: 28057070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research Progress of α-Synuclein Aggregation Inhibitors for Potential Parkinson's Disease Treatment.
    Kalsoom I; Wang Y; Li B; Wen H
    Mini Rev Med Chem; 2023; 23(20):1959-1974. PubMed ID: 37198991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression.
    Niu M; Li Y; Li G; Zhou L; Luo N; Yao M; Kang W; Liu J
    Eur J Neurol; 2020 Jun; 27(6):967-974. PubMed ID: 32150777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
    Dogra N; Mani RJ; Katare DP
    Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
    Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
    Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models.
    Su Y; Liu N; Zhang Z; Li H; Ma J; Yuan Y; Shi M; Liu J; Zhao Z; Zhang Z; Holscher C
    Eur J Pharmacol; 2022 Jul; 926():175029. PubMed ID: 35584709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A role of human microbiota in the development of neurodegenerative diseases].
    Epishina IV; Budanova EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(10):57-65. PubMed ID: 36279229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestine-derived α-synuclein initiates and aggravates pathogenesis of Parkinson's disease in Drosophila.
    Liu W; Lim KL; Tan EK
    Transl Neurodegener; 2022 Oct; 11(1):44. PubMed ID: 36253844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.